Globeflex Capital »

Sarepta Therapeutics shares owned by Globeflex Capital

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Globeflex Capital from 13F filings

Historical chart of Globeflex Capital investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Globeflex Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Globeflex Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $304k 14k 21.76

More positions owned by Globeflex Capital

Intercorp Financial Services (IFS)
Phibro Animal Health Corporati*on Cmn Class A (PAHC)
Blue Bird Corp (BLBD)
Exelixis (EXEL)
Catalyst Pharmaceutical Partners (CPRX)
Cirrus Logic (CRUS)
Ypf Sa (YPF)
Allegheny Technologies Incorporated (ATI)
Copa Holdings Sa-class A (CPA)
EnerSys (ENS)
Marex Group (MRX)
Credicorp (BAP)
ESCO Technologies (ESE)
MKS Instruments (MKSI)
Costamare (CMRE)

View all positions for Globeflex Capital

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
Vanguard Portfolio Management
State Street Corporation
AQR Capital Management
Two Sigma Investments
Vanguard Capital Management
First Trust Advisors
RA Capital Management
Susquehanna International
Erste Asset Management GmbH
Morgan Stanley
Standard Life Aberdeen
Citadel Advisors
UBS Group

View all funds holding Sarepta Therapeutics